These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6608957

  • 1. Active site of C3a anaphylatoxin: contributions of the lipophilic and orienting residues.
    Unson CG, Erickson BW, Hugli TE.
    Biochemistry; 1984 Feb 14; 23(4):585-9. PubMed ID: 6608957
    [Abstract] [Full Text] [Related]

  • 2. The active site of human C4a anaphylatoxin.
    Hugli TE, Kawahara MS, Unson CG, Molinar-Rode R, Erickson BW.
    Mol Immunol; 1983 Jun 14; 20(6):637-45. PubMed ID: 6603573
    [Abstract] [Full Text] [Related]

  • 3. The active site of C3a anaphylatoxin.
    Caporale LH, Tippett PS, Erickson BW, Hugli TE.
    J Biol Chem; 1980 Nov 25; 255(22):10758-63. PubMed ID: 6968751
    [Abstract] [Full Text] [Related]

  • 4. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.
    Glovsky MM, Hugli TE, Ishizaka T, Lichtenstein LM, Erickson BW.
    J Clin Invest; 1979 Sep 25; 64(3):804-11. PubMed ID: 89118
    [Abstract] [Full Text] [Related]

  • 5. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.
    Hugli TE, Erickson BW.
    Proc Natl Acad Sci U S A; 1977 May 25; 74(5):1826-30. PubMed ID: 266705
    [Abstract] [Full Text] [Related]

  • 6. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W, Kretzschmar T, Stühmer T, Kola A, Emde M, Köhl J, Klos A, Bitter-Suermann D.
    Biochem J; 1992 Nov 15; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [Abstract] [Full Text] [Related]

  • 7. Anaphylatoxin-induced neutrophil chemotaxis and aggregation. Limited aggregation and specific desensitization induced by human C3a and synthetic C3a octapeptides.
    Nagata S, Glovsky MM, Kunkel SL.
    Int Arch Allergy Appl Immunol; 1987 Nov 15; 82(1):4-9. PubMed ID: 3492446
    [Abstract] [Full Text] [Related]

  • 8. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP, Hugli TE, Bloor CM.
    Am J Pathol; 1980 Aug 15; 100(2):327-48. PubMed ID: 6967702
    [Abstract] [Full Text] [Related]

  • 9. Demonstration of a specific C3a receptor on guinea pig platelets.
    Fukuoka Y, Hugli TE.
    J Immunol; 1988 May 15; 140(10):3496-501. PubMed ID: 3283237
    [Abstract] [Full Text] [Related]

  • 10. Structure and function of the anaphylatoxins.
    Hugli TE.
    Springer Semin Immunopathol; 1984 May 15; 7(2-3):193-219. PubMed ID: 6387982
    [Abstract] [Full Text] [Related]

  • 11. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    Marceau F, Hugli TE.
    J Pharmacol Exp Ther; 1984 Sep 15; 230(3):749-54. PubMed ID: 6332191
    [Abstract] [Full Text] [Related]

  • 12. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C, Hugli TE.
    Proc Natl Acad Sci U S A; 1981 Mar 15; 78(3):1833-7. PubMed ID: 6940191
    [Abstract] [Full Text] [Related]

  • 13. Purification and partial characterization of human and porcine C3a anaphylatoxin.
    Hugli TE, Vallota EH, Müller-Eberhard HJ.
    J Biol Chem; 1975 Feb 25; 250(4):1472-8. PubMed ID: 803505
    [Abstract] [Full Text] [Related]

  • 14. Contraction of guinea pig lung by synthetic oligopeptides related to human C3a.
    Huey R, Erickson BW, Bloor CM, Hugli TE.
    Immunopharmacology; 1984 Aug 25; 8(1):37-45. PubMed ID: 6333413
    [Abstract] [Full Text] [Related]

  • 15. Effects of human anaphylatoxins on guinea pig atria.
    Huey R, Bloor CM, Hugli TE.
    Immunopharmacology; 1984 Dec 25; 8(3-4):147-54. PubMed ID: 6335143
    [Abstract] [Full Text] [Related]

  • 16. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
    Sorgenfrei J, Damerau B, Vogt W.
    Agents Actions; 1982 Apr 25; 12(1-2):118-21. PubMed ID: 6177210
    [Abstract] [Full Text] [Related]

  • 17. Helical conformation at the carboxy-terminal portion of human C3a is required for full activity.
    Hoeprich PD, Hugli TE.
    Biochemistry; 1986 Apr 22; 25(8):1945-50. PubMed ID: 3486674
    [Abstract] [Full Text] [Related]

  • 18. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.
    Burger R, Zilow G, Bader A, Friedlein A, Naser W.
    J Immunol; 1988 Jul 15; 141(2):553-8. PubMed ID: 2454995
    [Abstract] [Full Text] [Related]

  • 19. Contractile effect of the chemotactic factors f-Met-Leu-Phe and C5a on the human isolated umbilical artery. Role of cyclooxygenase products and tissue macrophages.
    Marceau F, deBlois D, Laplante C, Petitclerc E, Pelletier G, Grose JH, Hugli TE.
    Circ Res; 1990 Nov 15; 67(5):1059-70. PubMed ID: 1699682
    [Abstract] [Full Text] [Related]

  • 20. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.
    Stimler-Gerard NP.
    Complement; 1986 Nov 15; 3(3):137-51. PubMed ID: 3026723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.